Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Marsicano, Elisa De Oliveira ^a,b   Fernandes, Neimar Da Silva ^a   Colugnati, Fernando ^a,b   Grincenkov, Fabiane Rossi Dos Santos ^a,b   Fernandes, Natalia Maria Da Silva ^a,b   De Geest, Sabina ^c   Sanders Pinheiro, Helady ^a,b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b Núcleo Interdisciplinar de Estudos e Pesquisas em Nefrologia NIEPEN   (Brazil)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Immunosuppression; Medication nonadherence; Patient adherence; Transplantation; Validation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; BASEL ASSESSMENT OF ADHERENCE TO IMMUNOSUPPRESSIVE MEDICATIONS SCALE; BRAZIL; CONSTRUCT VALIDITY; CONTENT VALIDITY; CRITERION RELATED VALIDITY; CRONBACH ALPHA COEFFICIENT; CULTURAL ANTHROPOLOGY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERRATER RELIABILITY; INTRARATER RELIABILITY; KAPPA STATISTICS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PORTUGAL; PSYCHOMETRY; REPRODUCIBILITY; SELF REPORT; VALIDATION STUDY;

ADULT; BRAZIL; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PORTUGAL; PSYCHOMETRICS; QUESTIONNAIRES;

EID: 84877886697     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-108     Document Type: Article

References (40)

1. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B, Am J Transplant 2004 4 3 378 383 10.1111/j.1600-6143. 2004.00332.x 14961990 (Pubitemid 38282293)
2. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: A literature review. Denhaerynck K, Dobbels F, Cleemput I, Desmyttere A, Schäfer-Keller P, Schaub S, De Geest S, Transpl Int 2005 18 10 1121 1133 10.1111/j.1432-2277.2005.00176.x 16162098 (Pubitemid 41726755)
3. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Dew MA, DiMartini AF, De Vito Dabbs A, Myaskovsky L, Steel J, Unruh M, Switzer GE, Zomak R, Kormos RL, Greenhouse JB, Transplantation 2007 83 7 858 873 10.1097/01.tp.0000258599.65257.a6 17460556 (Pubitemid 46682726)
4. Clinical and economic consequences of non-adherence to immunosuppressive drugs in adult solid organ transplantation. Compliance in solid organ transplantation. De Geest S, Denhaerynck K, Dobbels F, International Transplantation Updates Barcelona, Spain: Permanyer Publications, Grinyó JM, 2011 63 81 [Invited Editor: Dr. Federico Oppenheimer]
5. Sabaté E, Adherence to long-term therapies: Evidence for action Geneva: World Health Organization 2003
6. Nonadherence consensus conference summary report. Fine RN, Becker Y, De Geest S, Eisen H, Ettenger R, Evans R, Rudow DL, McKay D, Neu A, Nevins T, Reyes J, Wray J, Dobbels F, Am J Transplant 2009 9 1 35 41 19133930
7. Transplant Procurement Management-TPM 2011 [ http://www.tpm.org ]
8. Registro Brasileiro de Transplante [ http://www.abto.com.br ]
9. The Emerging Role of Brazil in Clinical Trial Conduct for Transplantation. Tedesco HS Jr, Felipe CR, Abbud-Filho M, Garcia V, Medina-Pestana JO, Am J Transplant 2011 11 7 1368 1375 10.1111/j.1600-6143.2011. 03564.x 21668630
10. Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients. Denhaerynck K, Burkhalter F, Schäfer-Keller P, Steiger J, Bock A, De Geest S, Transpl Int 2009 22 4 441 446 10.1111/j.1432-2277.2008.00820.x 19144090
11. Frequency and impact of nonadherence to Immunosuppressants after renal transplantation: a systematic review. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC, Transplantation 2004 77 5 769 789 10.1097/01.TP.0000110408.83054.88 15021846 (Pubitemid 38366989)
12. Non-adherence to immunosuppressive drugs in transplantation: What can clinicians do? De Geest S, Burkhalter H, De Bleser L, Horne R, Mason JC, Journal of Renal Nursing 2010 2 58 63
13. Drug therapy: adherence to medication. Osterberg LB, N Engl Med 2005 353 5 487 497 10.1056/NEJMra050100 (Pubitemid 41127293)
14. The psychometric properties and practicability of self-report instruments to identify medication non-adherence in adult transplant patients to date: a systematic review. Dobbels F, Lut B, De Geest S, Drent G, Lennerling A, Whittaker C, Kugler C, Transplant360 Task Force, Transplantation 2010 90 2 205 219 10.1097/TP.0b013e3181e346cd 20531073
15. Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study. Schmiid-Mohler G, Thut MP, Wüthrich RP, Denhaerynck K, De Geest S, Clin Transplant 2009 10 213 222
16. Transplant360 Task Force [ http://www.transplant360.com ]
17. Cross-cultural adaptation and validation of health status measures. Guillemin F, Scand J Rheumatol 1995 24 2 61 63 10.3109/03009749509099285 7747144
18. Cross-cultural adaptation of health- related quality of life measures: literature review and proposed guidelines. Guillemin F, Bombardier C, Beaton D, J Clin Epidemiol 1993 46 12 1417 1432 10.1016/0895-4356(93)90142-N 8263569 (Pubitemid 24017263)
19. Quality criteria were proposed for measurement properties of health status questionnaires. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC, J Clin Epidemiol 2007 60 1 34 42 10.1016/j.jclinepi.2006.03.012 17161752 (Pubitemid 44856236)
20. An adaptation of Brislin's translation model for cross-cultural research. Jones PS, Jerry WL, Linda RP, Zhang XE, Jaceldo KB, Nurs Res 2001 50 5 300 304 10.1097/00006199-200109000-00008 11570715 (Pubitemid 33603821)
21. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. Walsh JC, Mandalia S, Gazzard BG, AIDS 2002 16 2 269 277 10.1097/00002030-200201250- 00017 11807312 (Pubitemid 34118574)
22. Validity and reliability of measurement instruments used in research. Kimberlin CL, Winterstein AG, Am J Health Syst Pharm 2008 65 23 2276 2284 10.2146/ajhp070364 19020196
23. Classical test theory. DeVellis RF, Med Care 2006 44 Suppl 3 50 59 10.1097/01.mlr.0000245426.10853.30 (Pubitemid 44632031)
24. Coefficient alpha and the internal structure of tests. Cronbach LJ, Psychometrika 1951 16 297 334 10.1007/BF02310555
25. Basic Statistics for Laboratories New York: Van Nostrand Reinhold, Kelly WD, Ratliff JTA, Nedadic C, 1992
26. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Delgado AB, Lima ML, Psicologia: Saúde e Doenças 2001 2 2 81 100 22269375
27. Factor analysis in the development and refinement of clinical assessment instruments. Floyd JF, Widaman KF, Psychol Assess 1995 7 286 289
28. Organization of a high-volume kidney transplant program-the "assembly line" approach. Medina-Pestana JO, Transplantation 2006 81 11 1510 1520 10.1097/01.tp.0000214934.48677.e2 16770238 (Pubitemid 43890886)
29. Incidência e fatores de risco para complicações infecciosas no primeiro ano após o transplante renal. Sousa SR, Galante NZ, Barbosa DA, Pestana JOM, Braz J Nephrol 2010 32 1 77 84
30. Validation of an English version of the Child-OIDP index, an oral health-related quality of life measure for children. Yusuf H, Gherunpong S, Sheiham A, Tsakos G, Health Qual Life Outcomes 2006 4 38 10.1186/1477-7525-4-38 16813660 (Pubitemid 44203876)
31. Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). Bengtsson M, Ohlsson B, Ulander K, BMC Gastroenterol 2007 7 16 10.1186/1471-230X-7-16 17475020 (Pubitemid 46785005)
32. Adapted version of the McGill pain questionnaire to Brazilian Portuguese. Varoli FK, Pedrazzi V, Braz Dent J 2006 17 4 328 335 17262148
33. Development and validation of an immunosuppressant therapy adherence instrument (ITAS). Chisholm MA, Lance CE, Williamson GM, Mulloy LL, Patient Educ Couns 2005 59 1 13 20 10.1016/j.pec.2004.09.003 16198214 (Pubitemid 41399874)
34. Concurrent and predictive validity of a self reported measure of medication adherence. Morisky D, Green L, Levine D, Medical Care 1986 249 1 67 74 (Pubitemid 16125389)
35. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Schäfer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S, Am J Transplant 2008 8 3 616 626 10.1111/j.1600-6143.2007.02127.x 18294158 (Pubitemid 351287554)
36. A comparison study of multiple measures of adherence to HIV protease inhibitors. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, Christian J, Maldonado T, Duran D, Kaplan AH, Wenger NS, Ann Intern Med 2001 134 10 968 977 10.7326/0003-4819-134-10-200105150-00011 11352698 (Pubitemid 32466236)
37. New findings about patient adherence to prescribed drug dosing regimens: An introduction to pharmionics. Urquhart J, Vrijens B, Eur J Hosp Pharm 2005 11 103 106
38. Insufficient cross-cultural adaptations and psychometric properties for many translated health assessment scales: A systematic review. Uysal-Bozkir O, Parlevliet JL, de Rooij SE, J Clin Epidemiol 2013 U Feb 15. Epub ahead of print
39. Medication noncompliance and its implications in transplant recipients. Morrissey EP, Flynn LM, Lin S, Drugs 2007 67 10 1463 1481 10.2165/00003495- 200767100-00007 17600393 (Pubitemid 47026394)
40. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR, Am J Transplant 2009 9 11 2597 2606 10.1111/j.1600-6143.2009.02798.x 19843035